This announcement is a separate document:
宜明昂科-B：自願公告 - IMM2510針對肺泡狀軟組織肉瘤的II期臨床試驗完成首例受試者入組給藥
IMMUNEONCO-B: VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN THE PHASE II CLINICAL TRIAL OFIMM2510 FOR THE TREATMENT OF ASPS
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.